| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
13,380,000 |
| Market
Cap: |
202.44(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$11.6 - $15.13 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
49,550 |
504,050 |
1,155,305 |
| Total Buy Value |
$0 |
$651,754 |
$6,240,948 |
$13,468,612 |
| Total People Bought |
0 |
1 |
2 |
4 |
| Total Buy Transactions |
0 |
2 |
13 |
36 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stewart Edward J. |
SVP & Pres, Healthcare Sol |
• – – |
2014-05-27 |
4 |
OE |
$1.25 |
$20,000 |
D/D |
16,000 |
37,385 |
|
- |
|
| Nielsen Ulrik B. |
SVP and CSO |
• – – |
2014-05-27 |
4 |
AS |
$8.01 |
$841,050 |
D/D |
(105,000) |
176,811 |
|
- |
|
| Nielsen Ulrik B. |
SVP and CSO |
• – – |
2014-05-27 |
4 |
OE |
$1.25 |
$133,550 |
D/D |
105,000 |
281,811 |
|
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-20 |
4 |
B |
$6.69 |
$26,760 |
D/D |
4,000 |
2,808,571 |
2.39 |
- |
|
| Quigley James H. |
Director |
– • – |
2014-05-19 |
4 |
B |
$6.58 |
$32,900 |
D/D |
5,000 |
56,500 |
2.39 |
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-19 |
4 |
B |
$6.71 |
$40,260 |
D/D |
6,000 |
2,804,571 |
2.39 |
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-16 |
4 |
B |
$6.63 |
$22,542 |
I/I |
3,400 |
2,798,571 |
2.1 |
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-16 |
4 |
B |
$6.50 |
$32,500 |
D/D |
5,000 |
535,865 |
2.39 |
- |
|
| Laivins Peter N |
SVP of DevelopmentOfficer |
• – – |
2014-05-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-14 |
4 |
B |
$6.49 |
$64,900 |
D/D |
10,000 |
530,865 |
2.39 |
- |
|
| Sinskey Anthony J |
Director |
– • – |
2014-05-13 |
4 |
B |
$6.74 |
$33,700 |
I/I |
5,000 |
397,543 |
2.1 |
- |
|
| Fehr Gordon J. |
Director |
– • – |
2014-05-12 |
4 |
OE |
$1.25 |
$31,250 |
D/D |
25,000 |
215,143 |
|
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-08 |
4 |
B |
$6.48 |
$32,400 |
D/D |
5,000 |
520,865 |
2.39 |
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-08 |
4 |
OE |
$1.71 |
$38,700 |
D/D |
20,000 |
515,865 |
|
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-07 |
4 |
B |
$6.70 |
$33,500 |
D/D |
5,000 |
495,865 |
2.39 |
- |
|
| Nash Sarah E |
Director |
– • – |
2014-05-07 |
4 |
B |
$6.79 |
$101,850 |
D/D |
15,000 |
955,296 |
2.39 |
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-07 |
4 |
B |
$6.77 |
$29,788 |
I/I |
4,400 |
2,795,171 |
2.1 |
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-06 |
4 |
B |
$6.85 |
$51,375 |
I/I |
7,500 |
2,790,771 |
2.1 |
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-05 |
4 |
B |
$6.12 |
$30,600 |
D/D |
5,000 |
490,865 |
2.39 |
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-05 |
4 |
B |
$6.92 |
$69,200 |
D/D |
10,000 |
2,783,271 |
2.39 |
- |
|
| Mulroy Robert J. |
President and CEO |
• • – |
2014-05-05 |
4 |
B |
$6.31 |
$31,550 |
D/D |
5,000 |
946,069 |
2.81 |
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-05 |
4 |
OE |
$1.25 |
$43,750 |
D/D |
35,000 |
2,773,271 |
|
- |
|
| Crocker Gary L |
Director |
– • – |
2014-05-05 |
4 |
B |
$6.69 |
$66,900 |
I/I |
10,000 |
2,738,271 |
2.1 |
- |
|
| Porter Michael E |
Director |
– • – |
2014-05-05 |
4 |
B |
$6.41 |
$96,150 |
D/D |
15,000 |
485,865 |
2.39 |
- |
|
| Nash Sarah E |
Director |
– • – |
2014-04-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
36,698 |
940,296 |
|
- |
|
410 Records found
|
|
Page 13 of 17 |
|
|
